Page 3 - Cajal University Hospital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cajal university hospital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cajal University Hospital Today - Breaking & Trending Today

Viral Load Tests, Initial Visits Reduced During Pandemic in People Living With HIV

A new study has found that initial visits and the number of viral load tests decreased during the COVID-19 pandemic but viral suppression and hospitalizations remained stable. ....

Management Systems Service , Infectious Diseases Department , Cajal University Hospital , Patient Information , Covid 19 , Initial Visits , Prepandemic Period , Postpandemic Period ,

'JAMA Neurology' publishes the results from Phase 1b/2a clinical trial of the neuroprotective drug ApTOLL for ischemic stroke

The results from APRIL study, previously presented at the International Stroke Conference 2023, indicate that ApTOLL showed good safety in 151 acute ischemic stroke patients.The article also highlights that the preliminary efficacy results show that ApTOLL significantly reduces mortality and long-term functional dis. ....

Israel General , Lhospitalet De Llobregat , Comunidad Autonoma De Cataluna , Cardona Portela , Macarena Hern , David Segarra , Hebron University Hospital , National Institutes Of Health , Octubre University Hospital , University Hospital In Sevilla Spain , Princesa University Hospital , European Union , University Hospital Complex Spain , International Stroke Conference , Cajal University Hospital , Toulouse University Hospital France , Spanish Ministry Of Science , Fe University Hospital , Bellvitge University Hospital , European Medicines Agency , University Clinical Hospital Of Valladolid Spain , Hospital University Of Lille France , Hebron Research Institute , Stroke Research Group , National Institutes , Stroke Scale ,

Chemo Avoidance Pays Off for Some Women With HER2+ Early BC

In the PHERGAIN trial, nearly all patients who were diverted from chemotherapy prior to surgery for HER2-positive early breast cancer survived without cancer recurrence for 3 years. ....

United States , Javier Cort , Kevin Kalinsky , American Society Of Clinical Oncology , Emory University Hospital , Cajal University Hospital , American Society , Clinical Oncology , Lancet Oncology , Breast Cancer , Alignant Breast Neoplasm , Biologic Therapy , Alignant Neoplasia , Antineoplastic Drug , Nti Cancer Agents , Targeted Therapy , Genomic Medicine , Edicine Genomic , Humanized Monoclonal Antibody , Hormone The ,

Chemo-Free Approach Works in Subset of Patients With HER2+ Early Breast Cancer

Impressive 3-year invasive DFS seen with adaptive response strategy using FDG-PET ....

United States , Mike Bassett , Javier Cort , American Society Of Clinical Oncology , Cajal University Hospital , American Society , Clinical Oncology ,

Hisense HD60 Demonstrated in Clinical Training at University Hospital of Valdecilla in Spain

/PRNewswire/ Hisense, a manufacturer and provider of high-performance electronics and medical devices, recently participated at Spain s University Hospital. ....

United Arab Emirates , South Africa , Prnewswire Hisense , Hisense Sa Sales Holdings Pty Ltd , Neurology Department Of Ram , Spain University Hospital Of Valdecilla , Cajal University Hospital , University Hospital , Hospital Humanization Index , Neurology Department , Cajal University , Health Care Amp Hospitals , Medical Pharmaceuticals , Medical Equipment ,